New Jersey Drug and Alcohol Outpatient Treatment Licensing

Author: A. Ant, CADC-II, Licensing & Accreditation Expert

Disclaimer: This content is provided for general informational purposes only and should not be construed as legal, regulatory, or licensing advice. Requirements change frequently. Consult qualified professionals for guidance specific to your situation.

Apply now: DOH Certificate of Need and Licensing, Integrated License | Integrated license questions: Integrated.License@doh.nj.gov | General CN&L intake: cnandlicensingrequests@doh.nj.gov

Outpatient substance use disorder treatment in New Jersey is now licensed under a structure that did not exist before 2026. N.J.A.C. 8:43K, the Manual of Standards for Licensure of Outpatient and Integrated Care Facilities, was adopted January 15, 2026 and took effect April 6, 2026. The same adoption repealed N.J.A.C. 10:161B, the old Standards for Licensure of Outpatient Substance Use Disorder Treatment Facilities. In its place is an integrated license that can cover SUD, mental health, opioid treatment, and primary care together, issued by the Department of Health, Division of Certificate of Need and Licensing (CN&L), not DMHAS.

One License Can Now Cover Multiple Service Lines

This consolidation is brand new, and plenty of operators are still planning around the old two-license structure. Before April 2026, an outpatient SUD program and an outpatient mental health program needed separate licenses even when run by the same organization at the same site. N.J.A.C. 8:43K changed that: a facility can now hold one integrated license covering mental health treatment, substance use disorder treatment, opioid treatment program services, primary care, and reproductive health, in whatever combination actually matches its program. If you’re planning a co-occurring-capable outpatient clinic, confirm with DOH exactly which services your application should list together under this new structure.

Your License Comes From DOH, Your Service Agreement From DMHAS

In our experience, sending an application to DMHAS by mistake is still one of the easiest errors to make on these filings. Part of the reason is that the division has moved twice. Under Reorganization Plan No. 001-2017 (effective August 28, 2017), DMHAS and its licensing functions left Human Services for the Department of Health. Plan No. 001-2018, effective August 20, 2018, reversed half of that: DMHAS returned to Human Services, while licensing and inspection of SUD and mental health facilities stayed with DOH. DMHAS serves as New Jersey’s Single State Agency for substance use and its State Mental Health Authority, and it doesn’t issue the facility license.

DMHAS is still part of your outpatient program’s life, though. Its companion rule, N.J.A.C. 10:36 (Behavioral Health Program Service Standards, effective April 6, 2026), applies to every facility DOH licenses under 8:43K to provide behavioral health services to adults in an outpatient setting, including OTPs. Under N.J.A.C. 10:36-3.1(a)1 the program must “have a contract or affiliation agreement with the DMHAS.” Budget time for that agreement alongside the DOH license, not after it.

No Certificate of Need for Standard Outpatient Care

This one is settled by statute. N.J.S.A. 26:2H-7a lists the services exempt from New Jersey’s Certificate of Need requirement, and “Outpatient drug and alcohol services” is on that list, along with non-bed outpatient mental health services and ambulatory care facilities. An outpatient SUD clinic can therefore go straight to the licensing application. If your plans later grow into beds, check DOH’s current Certificate of Need page before assuming the exemption carries over.

Medication for Opioid Use Disorder in Outpatient Care

An outpatient program treating opioid use disorder needs a clear medication pathway. Since DEA’s January 12, 2023 letter to registrants, a DATA-Waiver registration is no longer required to treat opioid use disorder with buprenorphine; a standard DEA registration number is enough. Naltrexone needs only ordinary prescribing privileges. Methadone is a different matter. Opioid treatment programs are licensed under N.J.A.C. 8:43K (the proposal placed them in their own subchapter), and N.J.A.C. 10:36 names OTPs among the program types its DMHAS service standards cover, so a methadone line brings both sets of requirements with it.

New Jersey Ketamine Practices: Ownership, Registration and Sedation Limits

We found no New Jersey statute or rule written for ketamine clinics. The facility-license and ownership conclusions below come from the statute and Board of Medical Examiners rules we cite, so treat them as our reading and confirm the structure with counsel and DOH.

The real constraints on a New Jersey ketamine clinic are ownership and the line between a private practice and a licensed facility. We found no rule closing the door on the clinic itself. The integrated license under N.J.A.C. 8:43K applies to an entity seeking licensure as an outpatient or integrated care facility, and N.J.S.A. 26:2H-2(b) defines a “health care service” while excluding “services provided by a physician in his private practice,” subject to exceptions in 26:2H-7 and 26:2H-12. Our reading is that a physician-owned office giving ketamine for depression is private practice and needs no DOH facility license. A clinic that adds ketamine under an existing 8:43K license is a different case. DOH told commenters that a facility wanting a new 8:43K service “will have to apply to add” it, so ask Integrated.License@doh.nj.gov whether ketamine counts as a new service on your license before you schedule anyone.

Ownership Has to Stay With Licensees

N.J.A.C. 13:35-6.16(e) is the rule that shapes the deal. A health care service “shall be owned solely by one or more licensed health care professionals.” A partnership, professional association or LLC practice must be composed solely of licensed health care professionals in the same or a closely allied field, and the rule lists nursing among those fields, so a physician and an advanced practice nurse can co-own. The same rule says “a practitioner with a plenary license shall not be employed by a practitioner with a limited scope of license.” Its examples are podiatrists, chiropractors and midwives rather than APNs, but our reading is that the principle also keeps an APN-owned practice from employing the physician. Investors come in through a management services organization, and 6.16(f)5 sets its limits: a general business corporation may provide only services “exclusively of a non-professional nature,” the licensee keeps sole discretion over patient fees, and the corporation can’t hold itself out to the public as offering the clinical services under its own name. Draft the management agreement to those three points.

Registrations, Protocols and Sedation Rules

The clinic needs a DEA registration and a New Jersey CDS registration at the address where ketamine is stored, and the two addresses must match. If an APN will order ketamine, settle in the joint protocol with the collaborating physician whether a physician consult comes first, since N.J.S.A. 45:11-49 makes every joint protocol answer that question for controlled substances. The PMP statute (N.J.S.A. 45:1-46.1) exempts a practitioner administering a CDS directly to a patient, though a take-home prescription is not direct administration. Watch the dose, too. The Board’s office anesthesia rules in N.J.A.C. 13:35-4A cover an anesthetic agent given “with the purpose of creating moderate sedation.” A sub-anesthetic depression protocol isn’t aimed at sedation, but a clinic whose protocol goes deeper is in office anesthesia territory, and the rest of 13:35-4A comes with it. Spravato adds the REMS: a certified setting and at least two hours of monitoring after each dose.

Sharing a building or a patient list with your 8:43K SUD program can work as long as the clinic holds its own charts, its own ketamine inventory and its own registrations, and addiction treatment records cross over only with the patient’s written consent. Referral arrangements between the two are covered in the ketamine section of New Jersey Drug and Alcohol Inpatient Treatment Licensing.

Staffing an Outpatient Program

A small outpatient program typically needs a clinical director and two to three counselors, and New Jersey’s counselor tier system is what actually keeps that affordable. BLS puts the New Jersey median for substance abuse, behavioral disorder, and mental health counselors at $64,710 a year (OEWS, May 2024); nationally it is roughly $59,350. Put a clinical director and two to three counselors together and clinical payroll commonly lands at $230,000 to $320,000 a year before benefits. Most New Jersey outpatient programs aren’t paying that number in full, and the counselor tier system is why. CADC certificates are issued by the State Board of Marriage and Family Therapy Examiners on the recommendation of its Alcohol and Drug Counselor Committee (N.J.A.C. 13:34C-1.2), and a CADC delivers services “under the supervision of a licensed professional” (13:34C-6.3) while building toward the LCADC. A common approach staffs the clinic with CADC-level counselors under an LCADC clinical director (who, to count as a qualified clinical supervisor under 13:34C-6.2, has also needed a current Certified Clinical Supervisor credential from an ICRC member board since June 2, 2021), which keeps payroll more manageable while giving staff a defined path to independent practice. We build the actual matrix and cost estimate after the program model is settled.

Filing the CN-7 for an Integrated License

The application is DOH’s form CN-7, filed with the fees set out in N.J.A.C. 8:43K-2.8. DMHAS’s 2026 overview of the integrated license sends questions about the outpatient integrated care application to Integrated.License@doh.nj.gov, and DOH’s general CN&L intake address remains cnandlicensingrequests@doh.nj.gov. List every service line you intend to run, and write policies and procedures for each one against 8:43K and 10:36.

Timing matters right now. According to that same DMHAS overview, applications received after May 1, 2026 need a full 8:43K application at 8:43K pricing, with full applications expected to be assigned beginning July 1, 2026. The overview also said all renewals were on hold, listed continuation letters for existing licensees, and said renewals would be issued under 8:43K from DOH’s Dynamics system. Once issued, the 8:43K license runs for two years (8:43K-2.5(c)), and 8:43K-2.6 allows license renewal by deemed status for accredited facilities. DOH declined to name the accrediting bodies in the rule, so confirm that yours qualifies before counting on it.

What Delays New Jersey Outpatient Applications

From what we see on these files, two mistakes cause most of the lost time. One is assuming DMHAS runs the licensing review, when CN&L at DOH does it and DMHAS handles the separate contract or affiliation agreement. The other is treating the integrated license as automatic for any service combination without checking with DOH, which is risky for a chapter that has only been in force since April 2026.

Frequently Asked Questions

Confirming which service combination your New Jersey integrated license should cover? Reach out here.

Sources

• NJ Department of Health, N.J.A.C. 8:43K: Notice of Adoption, Outpatient and Integrated Care Facilities (checked October 8, 2026)
• NJ Department of Health, N.J.A.C. 8:43K: Notice of Proposal, 57 N.J.R. 743(a) (checked October 8, 2026)
• NJ Department of Human Services, N.J.A.C. 10:36: Behavioral Health Program Service Standards, 58 N.J.R. 1382(a) (checked October 8, 2026)
• NJ DMHAS: Integrated License and Regulatory Scheme overview (2026) (checked October 8, 2026)
• NJ Department of Health: Integrated License page (checked October 8, 2026)
• NJ Department of Health: Form CN-7, Application for New or Amended Acute Care Facility License (checked October 8, 2026)
• NJ Department of Health: Health Facilities contacts, CN&L intake (checked October 8, 2026)
• N.J.S.A. 26:2H-7a (Justia mirror of official text): Certificate of Need exemptions (checked October 8, 2026)
• N.J.A.C. 13:34C-1.2, 6.2 and 6.3 (Justia mirror of official text): Alcohol and Drug Counselor rules (checked October 8, 2026)
• U.S. DEA Diversion Control: Dear Registrant letter on the DATA-Waiver, January 12, 2023 (checked October 8, 2026)
• SAMHSA: Naltrexone (checked October 8, 2026)
• NJ DMHAS: Division of Mental Health and Addiction Services home page (checked October 8, 2026)
• eCFR, 21 CFR 1308.13(c)(7): ketamine as a Schedule III depressant (checked October 9, 2026)
• U.S. FDA: Spravato prescribing information and Medication Guide, REMS and two-hour monitoring (checked October 9, 2026)
• N.J.S.A. 26:2H-2 (Justia mirror of official text): Definitions, health care service and the private practice exclusion (checked October 9, 2026)
• N.J.A.C. 13:35-6.16 (Justia mirror of official text): Professional practice structure (checked October 9, 2026)
• N.J.A.C. 13:35-4A.3 (Cornell LII mirror of official text): Office anesthesia definitions (checked October 9, 2026)
• N.J. Division of Consumer Affairs: CDS registration FAQ (checked October 9, 2026)
• N.J.S.A. 45:1-46.1 (Justia mirror of official text): When prescription monitoring information must be accessed (checked October 9, 2026)
• N.J.S.A. 45:11-49 (Justia mirror of official text): Permitted duties of advanced practice nurse, joint protocols (checked October 9, 2026)